ASTRAZEN.NS · AstraZeneca Pharma India Limited
India · RS rating 4 · As of 2026-10-14
| Price | 5,950.50 INR |
|---|---|
| 1-day change | +1.2% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 12 / 5 / 19 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 23 / 3 / 16 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -15.5% |
| Sales growth Q/Q | +18.0% |
| Distance from 52-week high | +39.5% |
| Market cap (USD) | $1.5B |